Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.678 USD | +4.31% |
|
+6.35% | -36.07% |
10/06 | BioSig Technologies Appoints Ferdinand Groenewald as Interim CFO | MT |
15/05 | Alaunos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-36.07% | 1.04Cr | |
+20.63% | 13TCr | |
+24.16% | 2.8TCr | |
-20.17% | 2.05TCr | |
-16.06% | 1.71TCr | |
-18.07% | 1.61TCr | |
-47.70% | 1.5TCr | |
+11.92% | 1.48TCr | |
+58.32% | 1.44TCr | |
+149.98% | 1.24TCr |
- Stock Market
- Equities
- TCRT Stock
- News Alaunos Therapeutics, Inc.
- Transcript : ZIOPHARM Oncology, Inc. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-11-2017 07